本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PTC Therapeutics Inc.

67.59
+1.942.96%
盤後67.590.00000.00%19:30 EDT
成交量:139.79萬
成交額:9,394.41萬
市值:56.41億
市盈率:-110.80
高:67.90
開:65.99
低:65.80
收:65.65
52周最高:90.87
52周最低:57.74
股本:8,346.08萬
流通股本:7,364.81萬
量比:1.42
換手率:1.90%
股息:- -
股息率:- -
每股收益(TTM):-0.6100
每股收益(LYR):7.78
淨資產收益率:-7740.12%
總資產收益率:2.46%
市淨率:-34.11
市盈率(LYR):8.69

資料載入中...

2025/01/03

重要事件披露

Form 8-K - Current report
2024/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/27

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/18

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/18

重要事件披露

Form 8-K - Current report
2024/08/27

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities